GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Coherus BioSciences Inc (FRA:8C5) » Definitions » Other Current Receivables

Coherus BioSciences (FRA:8C5) Other Current Receivables : €1.8 Mil (As of Mar. 2025)


View and export this data going back to 2014. Start your Free Trial

What is Coherus BioSciences Other Current Receivables?

Coherus BioSciences's Other Current Receivables for the quarter that ended in Mar. 2025 was €1.8 Mil.

Coherus BioSciences's quarterly Other Current Receivables declined from Sep. 2024 (€28.15 Mil) to Dec. 2024 (€10.52 Mil) but then stayed the same from Dec. 2024 (€10.52 Mil) to Mar. 2025 (€1.80 Mil).

Coherus BioSciences's annual Other Current Receivables stayed the same from Dec. 2022 (€0.00 Mil) to Dec. 2023 (€0.00 Mil) but then increased from Dec. 2023 (€0.00 Mil) to Dec. 2024 (€10.52 Mil).


Coherus BioSciences Other Current Receivables Historical Data

The historical data trend for Coherus BioSciences's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coherus BioSciences Other Current Receivables Chart

Coherus BioSciences Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 10.52

Coherus BioSciences Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 128.50 28.15 10.52 1.80

Coherus BioSciences Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.


Coherus BioSciences Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Coherus BioSciences's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Coherus BioSciences Business Description

Traded in Other Exchanges
Address
333 Twin Dolphin Drive, Suite 600, Redwood City, CA, USA, 94065
Coherus BioSciences Inc is a commercial-stage biopharmaceutical company focused on the research, development and commercialization of innovative immunotherapies to treat cancer. Coherus is developing an innovative immuno-oncology pipeline which includes multiple antibody immunotherapy candidates focused on enhancing the innate and adaptive immune responses to enable a robust antitumor immunologic response and enhance outcomes for patients with cancer.

Coherus BioSciences Headlines

No Headlines